Canlyniadau Chwilio - Mathios, Dimitrios

Why is immunotherapy for glioblastoma “Lag”-ging gan Mathios, Dimitrios, Lim, Michael

Cael y testun llawn Cael y testun llawn Cael y testun llawn

New Prospects for Molecular Targets for Chordomas gan Ozair, Mohammad Zeeshan, Shah, Pavan, Mathios, Dimitrios, Lim, Michael, Moss, Nelson S.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Synthesizing Molecular and Immune Characteristics to Move Beyond WHO Grade in Meningiomas: A Focused Review gan Kannapadi, Nivedha V., Shah, Pavan P., Mathios, Dimitrios, Jackson, Christopher M.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Reply to: Limitations of molecular testing in combination with computerized tomographic for lung cancer screening gan Mathios, Dimitrios, Bach, Peter B., Phallen, Jillian A., Scharpf, Robert B., Velculescu, Victor E.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use gan Bettegowda, Chetan, Upadhayaya, Meena, Evans, D. Gareth, Kim, AeRang, Mathios, Dimitrios, Hanemann, Clemens O.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Reduced CSF leak in complete calvarial reconstructions of microvascular decompression craniectomies using calcium phosphate cement gan Eseonu, Chikezie I., Goodwin, C. Rory, Zhou, Xin, Theodros, Debebe, Bender, Matthew T., Mathios, Dimitrios, Bettegowda, Chetan, Lim, Michael

Cael y testun llawn Cael y testun llawn Cael y testun llawn

IT-21 PD-1 BLOCKADE SHOWS SYNERGISTIC SURVIVAL, ANTI-TUMOR IMMUNE RESPONSE AND LONG-TERM MEMORY WITH INTERSTITIAL BUT NOT SYSTEMIC CHEMOTHERAPY: STUDY IN A MURINE GLIOBLASTOMA MODE... gan Mathios, Dimitrios, Phallen, Jillian, Park, Chul-Kee, Jackson, Christopher, Nicholas, Sarah, Tyler, Betty, Pardoll, Drew, Brem, Henry, Lim, Michael

Cael y testun llawn Cael y testun llawn

Spinal cord untethering and midline myelotomy for delayed, symptomatic post-traumatic syringomyelia due to retained ballistic fragments: case report gan Azad, Tej D., Materi, Joshua, Hwang, Brian Y., Mathios, Dimitrios, Lehner, Kurt R., Hansen, Landon, Bernhardt, Lydia J., Xia, Yuanxuan, Shah, Pavan P., Kannapadi, Nivedha V., Theodore, Nicholas

Cael y testun llawn Cael y testun llawn Cael y testun llawn

PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment gan Mathios, Dimitrios, Ruzevick, Jacob, Jackson, Christopher M., Xu, Haiying, Shah, Sagar, Taube, Janis M., Burger, Peter C., McCarthy, Edward F., Quinones-Hinojosa, Alfredo, Pardoll, Drew M., Lim, Michael

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Integrative analysis of DNA methylation suggests down-regulation of oncogenic pathways and reduced somatic mutation rates in survival outliers of glioblastoma gan Hwang, Taeyoung, Mathios, Dimitrios, McDonald, Kerrie L., Daris, Irene, Park, Sung-Hye, Burger, Peter C., Kim, Sojin, Dho, Yun-Sik, Carolyn, Hruban, Bettegowda, Chetan, Shin, Joo Heon, Lim, Michael, Park, Chul-Kee

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma gan Choi, John, Medikonda, Ravi, Saleh, Laura, Kim, Timothy, Pant, Ayush, Srivastava, Siddhartha, Kim, Young-Hoon, Jackson, Christina, Tong, Luqing, Routkevitch, Denis, Jackson, Christopher, Mathios, Dimitrios, Zhao, Tianna, Cho, Hyerim, Brem, Henry, Lim, Michael

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy gan Belcaid, Zineb, Berrevoets, Cor, Choi, John, van Beelen, Edward, Stavrakaki, Eftychia, Pierson, Tessa, Kloezeman, Jenneke, Routkevitch, Denis, van der Kaaij, Mariëlle, van der Ploeg, Alicia, Mathios, Dimitrios, Sleijfer, Stefan, Dirven, Clemens, Lim, Michael, Debets, Reno, Lamfers, Martine L M

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Anti–PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM gan Mathios, Dimitrios, Kim, Jennifer E., Mangraviti, Antonella, Phallen, Jillian, Park, Chul-Kee, Jackson, Christopher M., Garzon-Muvdi, Tomas, Kim, Eileen, Theodros, Debebe, Polanczyk, Magdalena, Martin, Allison M., Suk, Ian, Ye, Xiaobu, Tyler, Betty, Bettegowda, Chetan, Brem, Henry, Pardoll, Drew M., Lim, Michael

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model gan Belcaid, Zineb, Phallen, Jillian A., Zeng, Jing, See, Alfred P., Mathios, Dimitrios, Gottschalk, Chelsea, Nicholas, Sarah, Kellett, Meghan, Ruzevick, Jacob, Jackson, Christopher, Albesiano, Emilia, Durham, Nicholas M., Ye, Xiaobu, Tran, Phuoc T., Tyler, Betty, Wong, John W., Brem, Henry, Pardoll, Drew M., Drake, Charles G., Lim, Michael

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous system gan Maxwell, Russell, Luksik, Andrew S., Garzon-Muvdi, Tomas, Hung, Alice L., Kim, Eileen S., Wu, Adela, Xia, Yuanxuan, Belcaid, Zineb, Gorelick, Noah, Choi, John, Theodros, Debebe, Jackson, Christopher M., Mathios, Dimitrios, Ye, Xiaobu, Tran, Phuoc T., Redmond, Kristin J., Brem, Henry, Pardoll, Drew M., Kleinberg, Lawrence R., Lim, Michael

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastoma gan Harris-Bookman, Sarah, Mathios, Dimitrios, Martin, Allison M., Xia, Yuanxuan, Kim, Eileen, Xu, Haiying, Belcaid, Zineb, Polanczyk, Magdalena, Barberi, Theresa, Theodros, Debebe, Kim, Jennifer, Taube, Janis M., Burger, Peter C., Selby, Mark, Taitt, Corina, Korman, Alan, Ye, Xiaobu, Drake, Charles G., Brem, Henry, Pardoll, Drew M., Lim, Michael

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden gan Stone, Meredith L., Chiappinelli, Katherine B., Li, Huili, Murphy, Lauren M., Travers, Meghan E., Topper, Michael J., Mathios, Dimitrios, Lim, Michael, Shih, Ie-Ming, Wang, Tian-Li, Hung, Chien-Fu, Bhargava, Vipul, Wiehagen, Karla R., Cowley, Glenn S., Bachman, Kurtis E., Strick, Reiner, Strissel, Pamela L., Baylin, Stephen B., Zahnow, Cynthia A.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM gan Hung, Alice L., Maxwell, Russell, Theodros, Debebe, Belcaid, Zineb, Mathios, Dimitrios, Luksik, Andrew S., Kim, Eileen, Wu, Adela, Xia, Yuanxuan, Garzon-Muvdi, Tomas, Jackson, Christopher, Ye, Xiaobu, Tyler, Betty, Selby, Mark, Korman, Alan, Barnhart, Bryan, Park, Su-Myeong, Youn, Je-In, Chowdhury, Tamrin, Park, Chul-Kee, Brem, Henry, Pardoll, Drew M., Lim, Michael

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Reply to Haffner et al.: DNA hypomethylation renders tumors more immunogenic gan Stone, Meredith L., Chiappinelli, Katherine B., Li, Huili, Murphy, Lauren M., Travers, Meghan E., Topper, Michael J., Mathios, Dimitrios, Lim, Michael, Shih, Ie-Ming, Wang, Tian-Li, Hung, Chien-Fu, Bhargava, Vipul, Wiehagen, Karla R., Cowley, Glenn S., Bachman, Kurtis E., Strick, Reiner, Strissel, Pamela L., Baylin, Stephen B., Zahnow, Cynthia A.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma gan Patel, Mira A., Kim, Jennifer E., Theodros, Debebe, Tam, Ada, Velarde, Esteban, Kochel, Christina M., Francica, Brian, Nirschl, Thomas R., Ghasemzadeh, Ali, Mathios, Dimitrios, Harris-Bookman, Sarah, Jackson, Christopher C., Jackson, Christina, Ye, Xiaobu, Tran, Phuoc T., Tyler, Betty, Coric, Vladimir, Selby, Mark, Brem, Henry, Drake, Charles G., Pardoll, Drew M., Lim, Michael

Cael y testun llawn Cael y testun llawn Cael y testun llawn